'It's still working': More are living with cancer as era of targeted drugs takes hold

The era of targeted drugs has led to a record number of cancer patients surviving for at least five years. Currently, 7 out of 10 patients reach this milestone, marking a substantial increase from the 1970s, when fewer than half survived. This trend also shows growth compared to the mid-1990s, when the survival rate stood at 63%. These statistics highlight the ongoing effectiveness of modern medical treatments in extending the lives of those diagnosed.